Clinical Trials Directory

Trials / Conditions / Ovarian Sarcoma

Ovarian Sarcoma

18 registered clinical trials studyying Ovarian Sarcoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingSequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer
NCT07067255
Essen BiotechPhase 1 / Phase 2
RecruitingInternational PPB/DICER1 Registry
NCT03382158
Children's Hospitals and Clinics of Minnesota—
CompletedCarboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
NCT01652794
Case Comprehensive Cancer CenterPhase 1
CompletedA Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian T
NCT01283035
National Cancer Institute (NCI)Phase 2
CompletedPsychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
NCT01764802
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT01764789
Ohio State University Comprehensive Cancer CenterN/A
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedQuality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Wake Forest University Health SciencesN/A
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedTherapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
NCT01553539
Wake Forest University Health SciencesPhase 2
CompletedStereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignan
NCT01079832
Case Comprehensive Cancer CenterPhase 2
CompletedTemsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors
NCT00408655
National Cancer Institute (NCI)Phase 1
CompletedZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu
NCT00390234
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
NCT00245102
National Cancer Institute (NCI)Phase 2
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedVaccine Therapy in Treating Patients With Metastatic Cancer
NCT00020267
National Cancer Institute (NCI)Phase 1
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymph
NCT00004241
National Cancer Institute (NCI)Phase 1